Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition

Multidrug resistance (MDR) is regarded as one of the bottlenecks of successful clinical treatment for numerous chemotherapeutic agents. Multiple key regulators are alleged to be responsible for MDR and making the treatment regimens ineffective. In this review, we discuss MDR in relation to P-glycoprotein (P-gp) and its down-regulation by natural bioactive molecules. P-gp, a unique ATP-dependent membrane transport protein, is one of those key regulators which are present in the lining of the colon, endothelial cells of the blood brain barrier (BBB), bile duct, adrenal gland, kidney tubules, small intestine, pancreatic ducts and in many other tissues like heart, lungs, spleen, skeletal muscles, etc. Due to its diverse tissue distribution, P-gp is a novel protective barrier to stop the intake of xenobiotics into the human body. Over-expression of P-gp leads to decreased intracellular accretion of many chemotherapeutic agents thus assisting in the development of MDR. Eventually, the effectiveness of these drugs is decreased. P-gp inhibitors act by altering intracellular ATP levels which are the source of energy and/or by affecting membrane contours to increase permeability. However, the use of synthetic inhibitors is known to cause serious toxicities. For this reason, the search for more potent and less toxic P-gp inhibitors of natural origin is underway. The present review aims to recapitulate the research findings on bioactive constituents of natural origin with P-gp inhibition characteristics. Natural bioactive constituents with P-gp modulating effects offer great potential for semi-synthetic modification to produce new scaffolds which could serve as valuable investigative tools to recognize the function of complex ABC transporters apart from evading the systemic toxicities shown by synthetic counterparts. Despite the many published scientific findings encompassing P-gp inhibitors, however, this article stand alones because it provides a vivid picture to the readers pertaining to Pgp inhibitors obtained from natural sources coupled with their mode of action and structures. It provides first-hand information to the scientists working in the field of drug discovery to further synthesise and discover new P-gp inhibitors with less toxicity and more efficacies.

[1]  A. Hofmann,et al.  Dihydro‐β‐agarofurans from the Australian Endemic Rainforest Plant Denhamia pittosporoides Inhibit Leucine Transport in Prostate Cancer Cells , 2016 .

[2]  Hui Sun,et al.  Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents. , 2016, Biochimica et biophysica acta.

[3]  Wei Wei,et al.  Advances in plant-based inhibitors of P-glycoprotein , 2016, Journal of enzyme inhibition and medicinal chemistry.

[4]  N. Yellu,et al.  Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: Involvement of P-glycoprotein inhibition , 2016, Pharmacological reports : PR.

[5]  A. Bello,et al.  Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection , 2016, Antiviral Research.

[6]  Yuefei Wang,et al.  Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model , 2015, International journal of molecular sciences.

[7]  S. Misaka,et al.  Inhibitory Effects of Green Tea and (–)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein , 2015, PloS one.

[8]  J. Behravan,et al.  Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins. , 2015, Fitoterapia.

[9]  Maria-José U. Ferreira,et al.  Enhancing activity of antibiotics against Staphylococcus aureus: Zanthoxylum capense constituents and derivatives. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[10]  Sergio Martínez-Luis,et al.  Marine Natural Products as Breast Cancer Resistance Protein Inhibitors , 2015, Marine drugs.

[11]  T. Kawasaki,et al.  Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  T. Efferth,et al.  Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[13]  Sung-Wuk Jang,et al.  Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-κB activation , 2015, Molecular and Cellular Biochemistry.

[14]  K. Rameshkumar,et al.  Curcuma ecalcarata – new natural source of pinocembrin and piperitenone , 2015, Natural product research.

[15]  P. Babu,et al.  Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro , 2014, Drug development and industrial pharmacy.

[16]  L. Walker,et al.  Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents , 2014, Front. Pharmacol..

[17]  M. Wink,et al.  Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[18]  B. Li,et al.  In Vitro Inhibitory Effects of Scutellarin on Six Human/Rat Cytochrome P450 Enzymes and P-glycoprotein , 2014, Molecules.

[19]  Zhihao Liu,et al.  Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp. , 2014, Toxicology and applied pharmacology.

[20]  A. Wallqvist,et al.  Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. , 2014, Bioorganic & medicinal chemistry.

[21]  F. Lévi,et al.  Optimization of irinotecan chronotherapy with P-glycoprotein inhibition. , 2014, Toxicology and applied pharmacology.

[22]  Sergio Martínez-Luis,et al.  Marine Natural Products with P-Glycoprotein Inhibitor Properties , 2014, Marine drugs.

[23]  N. S. Yarla,et al.  Bioactive Flavonoids as ABC Transporters Inhibitors for Reversion of Multidrug Resistance in Cancer , 2013 .

[24]  M. Wink,et al.  Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[25]  Jin Si,et al.  Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression. , 2013, Molecular medicine reports.

[26]  A. Shafiee,et al.  Biological Activities and Pharmacokinetics of Praeruptorins from Peucedanum Species: A Systematic Review , 2013, BioMed research international.

[27]  O. Erez,et al.  Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines , 2013, PeerJ.

[28]  Shengyao Wang,et al.  Grape Seed Procyanidin Reversal of P-glycoprotein Associated Multi-Drug Resistance via Down-regulation of NF-κB and MAPK/ERK Mediated YB-1 Activity in A2780/T Cells , 2013, PloS one.

[29]  Jianping Chen,et al.  Natural Borneol, a Monoterpenoid Compound, Potentiates Selenocystine-Induced Apoptosis in Human Hepatocellular Carcinoma Cells by Enhancement of Cellular Uptake and Activation of ROS-Mediated DNA Damage , 2013, PloS one.

[30]  S. Srivastava,et al.  Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid‐Resistant Escherichia coli , 2013, Chemical biology & drug design.

[31]  Michael R Hamblin,et al.  Send Orders of Reprints at Reprints@benthamscience.net Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation , 2022 .

[32]  Z. Binkhathlan,et al.  P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. , 2013, Current cancer drug targets.

[33]  M. Wink,et al.  An isoquinoline alkaloid from the Chinese herbal plant Corydalis yanhusuo W.T. Wang inhibits P-glycoprotein and multidrug resistance-associate protein 1. , 2013, Food chemistry.

[34]  Ricardo J. Ferreira,et al.  Enhancing macrocyclic diterpenes as multidrug-resistance reversers: structure-activity studies on jolkinol D derivatives. , 2013, Journal of medicinal chemistry.

[35]  Ming Yan,et al.  Gambogic Acid as a Non‐Competitive Inhibitor of ATP‐Binding Cassette Transporter B1 Reverses the Multidrug Resistance of Human Epithelial Cancers by Promoting ATP‐Binding Cassette Transporter B1 Protein Degradation , 2013, Basic & clinical pharmacology & toxicology.

[36]  Quan Xia,et al.  Reversal of P‐glycoprotein‐mediated multidrug resistance of human hepatic cancer cells by Astragaloside II , 2012, The Journal of pharmacy and pharmacology.

[37]  R. Gambari,et al.  Phytochemical Analysis and Cytotoxicity Towards Multidrug-Resistant Leukemia Cells of Essential Oils Derived from Lebanese Medicinal Plants , 2012, Planta Medica.

[38]  Maria-José U. Ferreira,et al.  Jatrophane diterpenes from Euphorbia mellifera and their activity as P-glycoprotein modulators on multidrug-resistant mouse lymphoma and human colon adenocarcinoma cells. , 2012, Journal of natural products.

[39]  P. Lakshmi,et al.  Overview of P-glycoprotein inhibitors: a rational outlook , 2012 .

[40]  M. Wink,et al.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents , 2012, Front. Microbio..

[41]  Eunhye Kim,et al.  Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[42]  G. Du,et al.  Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood–brain barrier in in vitro cell experiments , 2012, Journal of Asian natural products research.

[43]  Minhee Kim,et al.  Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: Possible role of cytochrome p450 3A4 and P-glycoprotein inhibition by baicalein , 2011, Archives of pharmacal research.

[44]  Yong-long Han,et al.  Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[45]  K. Kwon,et al.  Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats , 2011, Xenobiotica; the fate of foreign compounds in biological systems.

[46]  Soo-Jin Jeong,et al.  Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel‐induced cytotoxicity and apoptosis via multidrug resistance reversal in MES‐SA/DX5 uterine sarcoma cells , 2011, Environmental toxicology.

[47]  N. Tinari,et al.  Strain- and Sex-Dependent Circadian Changes in Abcc2 Transporter Expression: Implications for Irinotecan Chronotolerance in Mouse Ileum , 2011, PloS one.

[48]  J. Molnár,et al.  Alkaloids derived from genus Veratrum and Peganum of Mongolian origin as multidrug resistance inhibitors of cancer cells. , 2011, Fitoterapia.

[49]  Y. Kashiwada,et al.  New 29-nor-cycloartanes with a 3,4-seco- and a novel 2,3-seco-structure from the leaves of Sinocalycanthus chinensis. , 2011, Bioorganic & medicinal chemistry.

[50]  Chie Suzuki,et al.  Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects , 2011, Cancer Chemotherapy and Pharmacology.

[51]  Andrew M. Piggott,et al.  Nocardioazines: a novel bridged diketopiperazine scaffold from a marine-derived bacterium inhibits P-glycoprotein. , 2011, Organic letters.

[52]  J. Behravan,et al.  Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines. , 2011, Planta medica.

[53]  Michael R Hamblin,et al.  Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria , 2011, PloS one.

[54]  Sang-Chul Shin,et al.  Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in Rats: Possible role of CYP3A4 and P-glycoprotein inhibition by myricetin , 2011, Archives of pharmacal research.

[55]  M. Morris,et al.  5,7-Dimethoxyflavone and Multiple Flavonoids in Combination Alter the ABCG2-Mediated Tissue Distribution of Mitoxantrone in Mice , 2011, Pharmaceutical Research.

[56]  H. Greger,et al.  Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[57]  S. Ignacimuthu,et al.  Antimycobacterial activity of two natural alkaloids, vasicine acetate and 2-acetyl benzylamine, isolated from Indian shrub Adhatoda vasica Ness. leaves , 2010, Journal of Biosciences.

[58]  D. Duś,et al.  8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1. , 2010, European journal of pharmacology.

[59]  Nicolas Tournier,et al.  Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). , 2010, The international journal of neuropsychopharmacology.

[60]  M. Kumar,et al.  Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. , 2010, The Journal of antimicrobial chemotherapy.

[61]  M. Iranshahi,et al.  Effect Of Galbanic Acid, A Sesquiterpene Coumarin From Ferula Szowitsiana, As An Inhibitor Of Efflux Mechanism In Resistant Clinical Isolates Of Staphylococcus Aureus , 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[62]  M. Rybczyńska,et al.  Phytosterols in physiological concentrations target multidrug resistant cancer cells. , 2010, Medicinal chemistry (Shariqah (United Arab Emirates)).

[63]  M. M. Rahman,et al.  Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. , 2010, The Journal of antimicrobial chemotherapy.

[64]  J. Pagés,et al.  Efflux Pumps Are Involved in the Defense of Gram-Negative Bacteria against the Natural Products Isobavachalcone and Diospyrone , 2010, Antimicrobial Agents and Chemotherapy.

[65]  S. Sharma,et al.  Modulation of P‐glycoprotein ATPase activity by some phytoconstituents , 2010, Phytotherapy research : PTR.

[66]  S. Yamada,et al.  Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells. , 2010, Biological & pharmaceutical bulletin.

[67]  M. Wink,et al.  Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. , 2010, European journal of pharmacology.

[68]  M. Wink,et al.  The beta‐carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells , 2010, Phytotherapy research : PTR.

[69]  S. Castanys,et al.  Novel dihydro-beta-agarofuran sesquiterpenes as potent modulators of human P-glycoprotein dependent multidrug resistance. , 2009, Organic & biomolecular chemistry.

[70]  M. F. Souza,et al.  Modulation of drug resistance in staphylococcus aureus by a kaempferol glycoside from herissantia tiubae (malvaceae) , 2009, Phytotherapy research : PTR.

[71]  Maria-José U. Ferreira,et al.  New potent P-glycoprotein modulators with the cucurbitane scaffold and their synergistic interaction with doxorubicin on resistant cancer cells. , 2009, Bioorganic & medicinal chemistry.

[72]  R. Bauer,et al.  Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. , 2009, Cancer genomics & proteomics.

[73]  Ming Yan,et al.  Inhibition of P‐glycoprotein function by procyanidine on blood–brain barrier , 2009, Phytotherapy research : PTR.

[74]  Zhe-Sheng Chen,et al.  Sipholane triterpenoids: chemistry, reversal of ABCB1/P-glycoprotein-mediated multidrug resistance, and pharmacophore modeling. , 2009, Journal of natural products.

[75]  A. Ali,et al.  Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA) , 2009, Current Microbiology.

[76]  Sushama Talegaonkar,et al.  Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[77]  Ho-jin Jung,et al.  Potent modulation of P‐glycoprotein activity by naturally occurring phenylbutenoids from Zingiber cassumunar , 2009, Phytotherapy research : PTR.

[78]  A. di Pietro,et al.  Jatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy , 2009, Phytochemistry Reviews.

[79]  Jiantao Ye,et al.  [Reversal effect and its mechanism of ampelopsin on multidrug resistance in K562/ADR cells]. , 2009, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[80]  J. Molnár,et al.  Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP1 transport activity by flavonoids , 2008, Cellular & Molecular Biology Letters.

[81]  G. Kruh,et al.  The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms. , 2008, Cancer research.

[82]  Xuehua Jiang,et al.  Intra-herb pharmacokinetics interaction between quercetin and isorhamentin , 2008, Acta Pharmacologica Sinica.

[83]  Q. Ma,et al.  Reversal effect of resveratrol on multidrug resistance in KBv200 cell line. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[84]  Maria-José U. Ferreira,et al.  Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells. , 2008, Bioorganic & medicinal chemistry.

[85]  M. VanNieuwenhze,et al.  A new total synthesis of patellamide A. , 2008, Organic letters.

[86]  M. Wink,et al.  Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[87]  J. Molnár,et al.  Antitumour properties of acridone alkaloids on a murine lymphoma cell line. , 2008, Anticancer research.

[88]  L. Lim,et al.  In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. , 2008, Toxicology and applied pharmacology.

[89]  S. Gibbons,et al.  Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. , 2008, The Journal of antimicrobial chemotherapy.

[90]  Ying-Jie Hu,et al.  Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells. , 2008, Journal of natural products.

[91]  S. Mertens-Talcott,et al.  Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. , 2008, Journal of agricultural and food chemistry.

[92]  H. Lou,et al.  Plagiochin E, a botanic‐derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump , 2008, Journal of applied microbiology.

[93]  Gleice da Graça Rocha,et al.  Natural triterpenoids from Cecropia lyratiloba are cytotoxic to both sensitive and multidrug resistant leukemia cell lines. , 2007, Bioorganic & medicinal chemistry.

[94]  S. Mertens-Talcott,et al.  Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. , 2007, Journal of pharmaceutical sciences.

[95]  S. Gibbons Phytochemicals for Bacterial Resistance - Strengths, Weaknesses and Opportunities , 2007, Planta medica.

[96]  Shufeng Zhou,et al.  Identification of drugs that interact with herbs in drug development. , 2007, Drug discovery today.

[97]  Simon Gibbons,et al.  The Phenolic Diterpene Totarol Inhibits Multidrug Efflux Pump Activity in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[98]  S. Gibbons,et al.  Antibacterial activity of two canthin‐6‐one alkaloids from Allium neapolitanum , 2007, Phytotherapy research : PTR.

[99]  L. Piddock,et al.  Bacterial efflux pump inhibitors from natural sources. , 2007, The Journal of antimicrobial chemotherapy.

[100]  S. Bates,et al.  Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure , 2007, Molecular Cancer Therapeutics.

[101]  J. Schellens,et al.  A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients , 2007, Clinical Cancer Research.

[102]  S. Akiyama,et al.  Reversal of P-glycoprotein-mediated multidrug resistance by sipholane triterpenoids. , 2007, Journal of natural products.

[103]  G. Kaatz,et al.  N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[104]  S. Mertens-Talcott,et al.  Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. , 2007, Journal of agricultural and food chemistry.

[105]  K. Linton,et al.  Structure and function of ABC transporters: the ATP switch provides flexible control , 2007, Pflügers Archiv - European Journal of Physiology.

[106]  D. Jang,et al.  P‐Glycoprotein Inhibitory Activity of Two Phenolic Compounds, (−)‐Syringaresinol and Tricin from Sasa borealis , 2007, Chemistry & biodiversity.

[107]  Naoko Yoshida,et al.  Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[108]  R. Bendayan,et al.  In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[109]  Chi-Keung Wan,et al.  Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells. , 2006, Biochemical pharmacology.

[110]  Sang-Un Choi,et al.  Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome ofCoptis japonica Makino , 2006, Archives of pharmacal research.

[111]  B. Trump,et al.  Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[112]  Sang-Un Choi,et al.  Aporphine alkaloids and their reversal activity of multidrug resistance (MDR) from the stems and rhizomes ofSinomenium acutum , 2006, Archives of pharmacal research.

[113]  R. Béliveau,et al.  Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. , 2006, Planta medica.

[114]  Maria-José U. Ferreira,et al.  Euphoportlandols A and B, tetracylic diterpene polyesters from Euphorbia portlandica and their anti-MDR effects in cancer cells. , 2006, Journal of natural products.

[115]  J. Donovan,et al.  Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana , 2006, Journal of Pharmacology and Experimental Therapeutics.

[116]  A. S. Lynch Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view. , 2006, Biochemical pharmacology.

[117]  K. Bostian,et al.  Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. , 2006, Biochemical pharmacology.

[118]  M. Chavez,et al.  Evidence-based drug--herbal interactions. , 2006, Life sciences.

[119]  J. Aponte,et al.  Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera. , 2006, Journal of natural products.

[120]  G. Kaatz,et al.  Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus. , 2006, Journal of natural products.

[121]  G. Tegos,et al.  Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus. , 2006, Journal of natural products.

[122]  Naoko Yoshida,et al.  Inhibition of P-glycoprotein-mediated transport by extracts of and monoterpenoids contained in Zanthoxyli fructus. , 2005, Toxicology and applied pharmacology.

[123]  A. Calcabrini,et al.  Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. , 2005, International journal of oncology.

[124]  K. Miyamoto,et al.  Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells. , 2005, Biological & pharmaceutical bulletin.

[125]  Maria-José U. Ferreira,et al.  Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones. , 2005, Anticancer research.

[126]  Roman Rouzier,et al.  Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma , 2005, Cancer.

[127]  J. Pagés,et al.  Inhibitors of efflux pumps in Gram-negative bacteria. , 2005, Trends in molecular medicine.

[128]  D. Clarke,et al.  Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug Efflux , 2005, The Journal of Membrane Biology.

[129]  P. van Bladeren,et al.  Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds. , 2005, Biochemical pharmacology.

[130]  H. Okumura,et al.  Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells , 2005, Cancer science.

[131]  S. Wolffram,et al.  Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT? , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[132]  E. Williamson,et al.  Isopimaric acid from Pinus nigra shows activity against multidrug‐resistant and EMRSA strains of Staphylococcus aureus , 2005, Phytotherapy research : PTR.

[133]  R. Béliveau,et al.  Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin , 2005, Cancer Chemotherapy and Pharmacology.

[134]  D. Clarke,et al.  Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"? , 2005, Biochemical and biophysical research communications.

[135]  J. Molnár,et al.  In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. , 2005, In vivo.

[136]  S. Kitagawa,et al.  Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. , 2005, Biochemical and biophysical research communications.

[137]  R. Ho,et al.  Characterization of the humanMDR1 gene , 2005, The AAPS Journal.

[138]  Mustafa Usta,et al.  Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. , 2005, Biochemical pharmacology.

[139]  D. Cohen,et al.  Efflux transporters and their clinical relevance. , 2005, Mini reviews in medicinal chemistry.

[140]  D. Clarke,et al.  The Dileucine Motif at the COOH Terminus of Human Multidrug Resistance P-glycoprotein Is Important for Folding but Not Activity* , 2005, Journal of Biological Chemistry.

[141]  E. Chieli,et al.  Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. , 2004, Life sciences.

[142]  I. Muhammad,et al.  Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide , 2004, Phytotherapy research : PTR.

[143]  G. Cook,et al.  Acquired Bacitracin Resistance in Enterococcus faecalis Is Mediated by an ABC Transporter and a Novel Regulatory Protein, BcrR , 2004, Antimicrobial Agents and Chemotherapy.

[144]  M. Hayashi,et al.  Cytotoxic effects and reversal of multidrug resistance by ibogan and related indole alkaloids. , 2004, Bioorganic & medicinal chemistry letters.

[145]  S. Akiyama,et al.  Kendarimide A, a novel peptide reversing P-glycoprotein-mediated multidrug resistance in tumor cells, from a marine sponge of Haliclona sp. , 2004 .

[146]  Y. Sugimoto,et al.  Phytoestrogens/Flavonoids Reverse Breast Cancer Resistance Protein/ABCG2-Mediated Multidrug Resistance , 2004, Cancer Research.

[147]  M. Morris,et al.  Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. , 2004, Molecular pharmacology.

[148]  D. Clarke,et al.  Val133 and Cys137 in Transmembrane Segment 2 Are Close to Arg935 and Gly939 in Transmembrane Segment 11 of Human P-glycoprotein* , 2004, Journal of Biological Chemistry.

[149]  S. Hladky,et al.  Interaction of the breast cancer resistance protein with plant polyphenols. , 2004, Biochemical and biophysical research communications.

[150]  P. Limtrakul,et al.  Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids , 2004, BMC Cancer.

[151]  D. Clarke,et al.  Disulfide Cross-linking Analysis Shows That Transmembrane Segments 5 and 8 of Human P-glycoprotein Are Close Together on the Cytoplasmic Side of the Membrane* , 2004, Journal of Biological Chemistry.

[152]  A. E. Senior,et al.  Synergy between Conserved ABC Signature Ser Residues in P-glycoprotein Catalysis* , 2004, Journal of Biological Chemistry.

[153]  L. Pardo,et al.  SAR studies of dihydro-beta-agarofuran sesquiterpenes as inhibitors of the multidrug-resistance phenotype in a Leishmania tropica line overexpressing a P-glycoprotein-like transporter. , 2004, Journal of medicinal chemistry.

[154]  A. Calcabrini,et al.  Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells. , 2003, International journal of oncology.

[155]  G. Chang Multidrug resistance ABC transporters , 2003, FEBS letters.

[156]  C. Dey,et al.  P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. , 2003, Pharmacological research.

[157]  C. Porter,et al.  Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[158]  H. Lage ABC-transporters: implications on drug resistance from microorganisms to human cancers. , 2003, International journal of antimicrobial agents.

[159]  A. Speciale,et al.  Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin. , 2003, International journal of antimicrobial agents.

[160]  Willem Boogerd,et al.  Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[161]  G. Tegos,et al.  Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[162]  D. Boger,et al.  Multidrug resistance reversal activity of key ningalin analogues. , 2003, Bioorganic & medicinal chemistry letters.

[163]  M. Ratain,et al.  Irinotecan treatment in cancer patients with UGT1A1 polymorphisms. , 2003, Oncology.

[164]  Shuzhong Zhang,et al.  Effects of the Flavonoids Biochanin A, Morin, Phloretin, and Silymarin on P-Glycoprotein-Mediated Transport , 2003, Journal of Pharmacology and Experimental Therapeutics.

[165]  P. Tulkens,et al.  Influence of P-Glycoprotein Inhibitors on Accumulation of Macrolides in J774 Murine Macrophages , 2003, Antimicrobial Agents and Chemotherapy.

[166]  S. Gibbons,et al.  Activity of Zanthoxylum clava‐herculis extracts against multi‐drug resistant methicillin‐resistant Staphylococcus aureus (mdr‐MRSA) , 2003, Phytotherapy research : PTR.

[167]  C. Choi,et al.  Reversal of P-Glycoprotein-Mediated Multidrug Resistance by Protopanaxatriol Ginsenosides from Korean Red Ginseng , 2003, Planta medica.

[168]  C. Gattass,et al.  Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. , 2003, Cancer letters.

[169]  P. Augustijns,et al.  The effect of food components on the absorption of P‐gp substrates: a review , 2003, The Journal of pharmacy and pharmacology.

[170]  M. Morris,et al.  Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. , 2003, Journal of Pharmacy and Science.

[171]  G. Tegos,et al.  Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. , 2002, Planta medica.

[172]  Y. Pommier,et al.  Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743. , 2002, Molecular cancer therapeutics.

[173]  R. Agarwal,et al.  Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. , 2002, Clinical Cancer Research.

[174]  E. Schuetz,et al.  Interaction of Cytochrome P450 3A Inhibitors with P-Glycoprotein , 2002, Journal of Pharmacology and Experimental Therapeutics.

[175]  K. Hahm,et al.  Reversal of P-glycoprotein-mediated multidrug resistance by 5,6,7,3',4'-pentamethoxyflavone (Sinensetin). , 2002, Biochemical and biophysical research communications.

[176]  Ling He,et al.  Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. , 2002, Acta pharmacologica Sinica.

[177]  Z. Ding,et al.  The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. , 2002, Biochemical pharmacology.

[178]  R. Béliveau,et al.  Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. , 2002, Biochimica et biophysica acta.

[179]  V. Skulachev,et al.  Transfer of Cationic Antibacterial Agents Berberine, Palmatine, and Benzalkonium Through Bimolecular Planar Phospholipid Film and Staphylococcus aureus Membrane , 2001, IUBMB life.

[180]  M. Kuroda,et al.  The emergence and evolution of methicillin-resistant Staphylococcus aureus. , 2001, Trends in microbiology.

[181]  J. Pezzuto,et al.  Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. , 2001, Cancer research.

[182]  K. Gallicano,et al.  An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[183]  C. Higgins,et al.  ABC transporters: physiology, structure and mechanism--an overview. , 2001, Research in microbiology.

[184]  M. Liscovitch,et al.  Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. , 2001, Anticancer research.

[185]  B. Chauffert,et al.  Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes , 2000, Leukemia.

[186]  T. Tsuruo,et al.  Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. , 2000, Cancer letters.

[187]  L. Mayer,et al.  Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[188]  G. Szakács,et al.  MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping* , 2000, The Journal of Biological Chemistry.

[189]  Y. Sawada,et al.  Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco‐2 cells and on the activity of cytochrome P450 3A4 , 2000, British journal of pharmacology.

[190]  I. Pastan,et al.  Analysis of the properties of the N-terminal nucleotide-binding domain of human P-glycoprotein. , 2000, Biochemistry.

[191]  T. Tsuruo,et al.  Effect of bioflavonoids on vincristine transport across blood-brain barrier. , 2000, European journal of pharmacology.

[192]  S. Gibbons,et al.  The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant , 2000, Phytotherapy research : PTR.

[193]  D. Back,et al.  Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. , 1999, British journal of clinical pharmacology.

[194]  M. Hayashi,et al.  Reversal of multidrug resistance by kopsiflorine isolated from Kopsia dasyrachis. , 1999, Planta medica.

[195]  Li-Wei Hung,et al.  Crystal structure of the ATP-binding subunit of an ABC transporter , 1998, Nature.

[196]  M. Grant,et al.  The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. , 1998, Chemico-biological interactions.

[197]  F. Schmitz,et al.  New cyclic peptides from the ascidian Lissoclinum patella. , 1998, Journal of natural products.

[198]  M. Hayashi,et al.  Reversal of multidrug resistance (MDR) by aspidofractinine-type indole alkaloids. , 1998, Bioorganic & medicinal chemistry letters.

[199]  H. Grunicke,et al.  PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1. , 1998, Biochemical pharmacology.

[200]  I. Pastan,et al.  Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. , 1998, Biochemistry.

[201]  S. Akiyama,et al.  Agosterol A, a Novel Polyhydroxylated Sterol Acetate Reversing Multidrug Resistance from a Marine Sponge of Spongia sp. , 1998 .

[202]  W. Bornmann,et al.  Reversal of anticancer multidrug resistance by the ardeemins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[203]  Sang-Un Choi,et al.  The bis benzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance‐related drugs via modulation of P‐glycoprotein , 1998, Anti-cancer drugs.

[204]  I. Paulsen,et al.  Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.

[205]  P. Giannakakou,et al.  The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. , 1997, Molecular pharmacology.

[206]  K. Kohn,et al.  Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[207]  H. Tian,et al.  Modulation of multidrug resistance by three bisbenzyl-isoquinolines in comparison with verapamil. , 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[208]  K. Ueda,et al.  How does P-glycoprotein recognize its substrates? , 1997, Seminars in cancer biology.

[209]  Piet Borst,et al.  MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine , 1996, Cell.

[210]  A. Quesada,et al.  Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein. , 1996, British Journal of Cancer.

[211]  J. Samuelson,et al.  Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. , 1995, Gene.

[212]  C. Jacquelinet,et al.  Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay. , 1995, Leukemia.

[213]  T. Tsuruo,et al.  Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro. , 1995, Biochemical pharmacology.

[214]  Richard E. Moore,et al.  Hapalosin, a Cyanobacterial Cyclic Depsipeptide with Multidrug- Resistance Reversing Activity. , 1995 .

[215]  J. T. Zilfou,et al.  Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance. , 1995, Molecular pharmacology.

[216]  G. Cordell,et al.  Indole alkaloids from Peschiera laeta that enhance vinblastine-mediated cytotoxicity with multidrug-resistant cells. , 1994, Journal of natural products.

[217]  T. Tsuruo,et al.  Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52. , 1994, Biochemical pharmacology.

[218]  G. C. Yeh,et al.  Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. , 1994, Biochemical pharmacology.

[219]  M. Ouellette,et al.  P-glycoprotein overexpression in methotrexate-resistant Leishmania tropica. , 1994, Biochemical pharmacology.

[220]  G. C. Yeh,et al.  Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. , 1993, Cancer research.

[221]  O. Fardel,et al.  Detection of P glycoprotein activity on normal and leukemic CD34+ cells. , 1993, Leukemia research.

[222]  R. Jacobs,et al.  A marine natural product, patellamide D, reverses multidrug resistance in a human leukemic cell line. , 1993, Cancer letters.

[223]  R. Arceci,et al.  Constitutive expression of multidrug resistance in human colorectal tumours and cell lines. , 1993, British Journal of Cancer.

[224]  J. Phillipson,et al.  Antimalarial activity of Artemisia annua flavonoids from whole plants and cell cultures , 1992, Plant Cell Reports.

[225]  I. Roninson,et al.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells , 1991, Cell.

[226]  H. Garewal,et al.  Expression of the multidrug resistance gene product (P‐glycoprotein) in myelodysplasia is associated with a stem cell phenotype , 1991, British journal of haematology.

[227]  Frank Koehn,et al.  Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata , 1990 .

[228]  J. Bourhis,et al.  Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. , 1989, Journal of the National Cancer Institute.

[229]  I. Pastan,et al.  MDR1 gene expression in lung cancer. , 1989, Journal of the National Cancer Institute.

[230]  H. Wieand,et al.  Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. , 1989, Cancer research.

[231]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[232]  V. Ling,et al.  Reduced permeability in CHO cells as a mechanism of resistance to colchicine , 1974, Journal of cellular physiology.

[233]  I. Ieiri Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2). , 2012, Drug metabolism and pharmacokinetics.

[234]  Jin-jian Lu,et al.  The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells , 2011, Molecular and Cellular Biochemistry.

[235]  Maria-José U. Ferreira,et al.  Inhibition of efflux pumps in methicillin-resistant Staphylococcus aureus and Enterococcus faecalis resistant strains by triterpenoids from Momordica balsamina. , 2011, International journal of antimicrobial agents.

[236]  A. di Pietro,et al.  Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla. , 2009, Fitoterapia.

[237]  K. Kang,et al.  Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol. , 2009, Die Pharmazie.

[238]  R. Aliya,et al.  Seaweed as a new source of flavone, scutellarein 4'-methyl ether , 2009 .

[239]  Jun-shik Choi,et al.  Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats. , 2008, Biopharmaceutics & drug disposition.

[240]  J. Kulbacka,et al.  Cytosolic superoxide dismutase activity after photodynamic therapy, intracellular distribution of Photofrin II and hypericin, and P-glycoprotein localization in human colon adenocarcinoma. , 2007, Folia histochemica et cytobiologica.

[241]  M. Hennessy,et al.  A primer on the mechanics of P-glycoprotein the multidrug transporter. , 2007, Pharmacological research.

[242]  Maria-José U. Ferreira,et al.  Apoptosis induction and modulation of P-glycoprotein mediated multidrug resistance by new macrocyclic lathyrane-type diterpenoids. , 2007, Bioorganic & medicinal chemistry.

[243]  M. Totrov,et al.  Waltzing transporters and 'the dance macabre' between humans and bacteria , 2007, Nature Reviews Drug Discovery.

[244]  H. Kwon,et al.  Isolation of limonoids and alkaloids fromPhellodendron amurense and their multidrug resistance (MDR) reversal activity , 2007, Archives of pharmacal research.

[245]  Maria-José U. Ferreira,et al.  Inhibition of multidrug resistance of cancer cells by natural diterpenes, triterpenes and carotenoids. , 2006, Current pharmaceutical design.

[246]  S. Kimura,et al.  Inhibition of leukemic cell growth by a novel anti‐cancer drug (GUT‐70) from calophyllum brasiliense that acts by induction of apoptosis , 2005, International journal of cancer.

[247]  Edward J Kelly,et al.  Characterization of the human MDR1 gene. , 2005, The AAPS journal.

[248]  P. Limtrakul,et al.  SCREENING OF FLAVONOIDS FOR THEIR POTENTIAL INHIBITORY EFFECT ON P-GLYCOPROTEIN ACTIVITY IN HUMAN CERVICAL CARCINOMA KB CELLS , 2004 .

[249]  Ding Yan-fang Reversal of adriamycin resistance by matrine in leukemia multidrug resistance cell line K562/ADM , 2004 .

[250]  Zheng Shu Cellular biological effects of matrine on K562 and K562/Vin cells , 2002 .

[251]  M. Wink Medicinal Natural Products. A Biosynthetic Approach , 2002 .

[252]  L. Doyle,et al.  Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. , 2000, Cancer research.

[253]  I. Pastan,et al.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.

[254]  A. Seelig How does P-glycoprotein recognize its substrates? , 1998, International journal of clinical pharmacology and therapeutics.

[255]  G. Barnett,et al.  Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11 , 1997, Cancer Chemotherapy and Pharmacology.

[256]  P. Dewick,et al.  Medicinal Natural Products: A Biosynthetic Approach , 1997 .

[257]  C. Wilson,et al.  Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. , 1993, Molecular and biochemical parasitology.

[258]  Y. C. Chen,et al.  Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[259]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[260]  B. Sikic,et al.  Multidrug Resistance ( mdr l ) Gene Expression in Adult Acute Leukemias : Correlations With Treatment Outcome and In Vitro Drug Sensitivity , 2003 .

[261]  J. Gariépy,et al.  Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[262]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[263]  M. Gottesman,et al.  Multidrug resistance in the laboratory and clinic. , 1989, Cancer cells.